Lowering B-type natriuretic peptide levels and increasing cardiac function: the role of levosimendan in the treatment of heart failure
Objective In this study, we examined whether levosimendan could lower B-type natriuretic peptide (BNP) and improve cardiac function in patients with heart failure who have diuretic resistance and low ejection fraction. Methods We conducted a cohort study among 120 participants from September 2022 to...
Saved in:
Main Authors: | Jianfeng Meng, Ye Zuo |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-02-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605241311434 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Associates of an Elevated Natriuretic Peptide Level in Stable Heart Failure Patients: Implications for Targeted Management
by: Aftab Jan, et al.
Published: (2013-01-01) -
Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients
by: Laura Leto, et al.
Published: (2015-01-01) -
NT-Pro-B-Type Natriuretic Peptide Levels in Infants with Failure to Thrive due to Caloric Deprivation
by: L. B. Mänhardt, et al.
Published: (2010-01-01) -
Efficiency and Safety of Prolonged Levosimendan Infusion in Patients with Acute Heart Failure
by: Georgios Aidonidis, et al.
Published: (2011-01-01) -
Significance of N-terminal pro-B-type natriuretic peptide levels in lung cancer
by: Sinem İnan, et al.
Published: (2025-01-01)